Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Von Eschenbach Confirmation Clears Holds At Tail-End Of Lame Duck

This article was originally published in The Tan Sheet

Executive Summary

Andrew von Eschenbach's nomination to be FDA commissioner cleared the Senate by a comfortable 80-11 margin on Dec. 7, ending months of "holds" on the vote and opposition from both sides of the aisle
Advertisement

Related Content

Election 2008: Both Candidates Are Likely To Change FDA’s Direction
Election 2008: Both Candidates Are Likely To Change FDA’s Direction
Election 2008: Both Candidates Are Likely To Change FDA’s Direction
Adverse Events Reporting System Needs Immediate Upgrade – FDA Consultant
Adverse Events Reporting System Needs Immediate Upgrade – FDA Consultant
Releasing IoM Drug Safety Report Could Be Early On Von Eschenbach’s Watch
Congressional Oversight “Misunderstood” By Von Eschenbach – Grassley
Crawford Pleads Guilty Of Failing To Disclose Stocks In Firms FDA Regulates
New Von Eschenbach Holds From Right Will Not Block HELP Committee Vote
New Von Eschenbach Holds From Right Will Not Block HELP Committee Vote

Topics

Advertisement
UsernamePublicRestriction

Register

PS100038

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel